Ingenox Therapeutics Limited is a private limited company situated at Magdalen Centre Robert Robinson Avenue, Oxford Science Park, Oxford OX4 4GA. Incorporated on 2022-05-24, this 1-year-old company is run by 6 directors.
Director James N., appointed on 22 December 2022. Director Simon K., appointed on 22 December 2022. Director Nicholas D., appointed on 22 December 2022.
The company is categorised as "activities of other holding companies n.e.c." (SIC: 64209), "research and experimental development on biotechnology" (Standard Industrial Classification code: 72110). According to Companies House data there was a name change on 2023-01-26 and their previous name was Celleron Therapeutics Holdings Limited.
The latest confirmation statement was filed on 2023-05-23 and the date for the subsequent filing is 2024-06-06. What is more, the accounts were filed on 30 June 2023 and the next filing is due on 31 March 2025.
| Office Address | Magdalen Centre Robert Robinson Avenue |
| Office Address2 | Oxford Science Park |
| Town | Oxford |
| Post code | OX4 4GA |
| Country of origin | United Kingdom |
| Registration Number | 14127227 |
| Date of Incorporation | Tue, 24th May 2022 |
| Industry | Activities of other holding companies n.e.c. |
| Industry | Research and experimental development on biotechnology |
| End of financial Year | 30th June |
| Company age | 2 years old |
| Account next due date | Mon, 31st Mar 2025 (334 days left) |
| Account last made up date | Fri, 30th Jun 2023 |
| Next confirmation statement due date | Thu, 6th Jun 2024 (2024-06-06) |
| Last confirmation statement dated | Tue, 23rd May 2023 |
Position: Director
Appointed: 22 December 2022
Position: Director
Appointed: 22 December 2022
Position: Director
Appointed: 22 December 2022
Position: Director
Appointed: 22 December 2022
Position: Director
Appointed: 24 May 2022
Position: Director
Appointed: 24 May 2022
The list of persons with significant control that own or have control over the company consists of 1 name. As we researched, there is Nicholas L. The abovementioned PSC has 75,01-100% voting rights and has 75,01-100% shares.
Nicholas L.
| Notified on | 24 May 2022 |
| Ceased on | 22 December 2022 |
| Nature of control: |
75,01-100% shares 75,01-100% voting rights right to appoint and remove directors |
| Celleron Therapeutics Holdings | January 26, 2023 |
| Type | Category | Free download | |
|---|---|---|---|
| SH01 |
3222.89 GBP is the capital in company's statement on 2024/03/01 filed on: 1st, March 2024 |
capital | Free Download (3 pages) |
© bizstats.co.uk 2024.
Terms of Use and Privacy Policy